(Q51496026)

5 April 2018

title

Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males. (English)

1 reference

5 April 2018

1 reference

Pöykkö SM

1

1 reference

5 April 2018

Kellokoski E

2

1 reference

5 April 2018

Ukkola O

3

1 reference

5 April 2018

Kauma H

4

1 reference

5 April 2018

Päivänsalo M

5

1 reference

5 April 2018

Kesäniemi YA

6

1 reference

5 April 2018

Hörkkö S

7

1 reference

5 April 2018

language of work or name

English

0 references

publication date

1 July 2006

1 reference

5 April 2018

Journal of Internal Medicine

published in

1 reference

5 April 2018

volume

260

1 reference

5 April 2018

issue

1

1 reference

5 April 2018

page(s)

43-52

1 reference

5 April 2018

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

[125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Ghrelin induces adiposity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

G-protein-coupled receptors in human atherosclerosis: comparison of vasoconstrictors (endothelin and thromboxane) with recently de-orphanized (urotensin-II, apelin and ghrelin) receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Ghrelin induces vasoconstriction in the rat coronary vasculature without altering cardiac peptide secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Plasma ghrelin, body fat, insulin resistance, and smoking in clinically healthy men: the atherosclerosis and insulin resistance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Regulation of endothelial cell apoptosis in atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Vasodilatory effect of ghrelin, an endogenous peptide from the stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Increased plasma ghrelin levels in chronic renal failure are not associated with hemodynamic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Estrogen replacement therapy increases plasma ghrelin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Post-prandial decrease of circulating human ghrelin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Food fails to suppress ghrelin levels in obese humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Ghrelin, macronutrient intake and dietary preferences in long-evans rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Anatomical and functional evidence for a neural hypothalamic-testicular pathway that is independent of the pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01661.X

10.1111/J.1365-2796.2006.01661.X

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018